The success of copyright’s blockbuster initially fueled a surge for major pharmaceutical companies, but recent developments present a complicated outlook for shareholders. Off-patent competitors are eroding revenue, https://joyceoasf697289.suomiblog.com/sildenafil-and-big-pharma-a-risky-bet-57003836